A0A0S2Z391 (A0A0S2Z391_HUMAN) Homo sapiens (Human)
BCL2-antagonist/killer 1 isoform 1 UniProtKBInterProInteractive Modelling
211 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: Q16611
Available Structures
48 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| The NMR structure of the BID-BAK complex |
Heteromer P55957; Q16611; | 100 | ||||
| K113-Ubiquitinated BAK |
Heteromer P62979; Q16611; | 99.41 | ||||
| Crystal Structure of human BAK in complex with M3W5_BID |
Heteromer P55957; Q16611; | 98.73 | 1×CU; | |||
| Bak core latch dimer in complex with Bim-h3Pc-RT |
Heteromer O43521; Q16611; | 99.35 | 2×PO4; | |||
| Bak in complex with Bim-h3Pc |
Heteromer O43521; Q16611; | 99.39 | 2×1PG; 1×NH4; | |||
| Bak core latch dimer in complex with Bim-BH3 - Cubic |
Heteromer O43521; Q16611; | 99.39 | 1×TFA; 6×EDO; 1×CL; 1×GOL; | |||
| Bak in complex with Bim-h3Glg |
Heteromer O43521; Q16611; | 99.39 | 6×MG; 1×EDO; | |||
| Bak core latch dimer in complex with Bim-h0-h3Glt |
Heteromer O43521; Q16611; | 99.32 | 3×EDO; | |||
| Bak core latch dimer in complex with Bim-RT - Tetragonal |
Heteromer O43521; Q16611; | 99.3 | 1×MPD; 2×BR; 1×IMD; | |||
| Human BAK in complex with the dF2 peptide |
Heteromer Q16611; | 99.37 | ||||
| Crystal Structure of human BAK in complex with W3W5_BID |
Heteromer P55957; Q16611; | 100.0 | ||||
| Human BAK in complex with the dF3 peptide |
Heteromer Q16611; | 99.36 | ||||
| Human BAK in complex with the dM2 peptide |
Heteromer Q16611; | 99.35 | ||||
| Crystal structure of Bak bound to Bnip5 BH3 |
Heteromer P0C671; Q16611; | 99.35 | ||||
| Crystal structure of human BAK in complex with the Pxt1 BH3 domain |
Heteromer Q16611; Q8NFP0; | 99.35 | ||||
| Crystal structure of BAK in complex with inhibiting antibody 14G6 |
Heteromer Q16611; | 99.31 | 1×SO4; 3×CCN; 3×PEG; 1×144; 2×PGE; | |||
| Crystal structure of BAK L100A in complex with activating antibody fragments |
Heteromer Q16611; | 98.51 | 3×MPD; | |||
| Crystal structure of BAK-BAX heterodimer with lysoPC |
Heteromer Q07812; Q16611; | 100 | 3×K6G; 1×ZN; 2×NA; 2×PEG; 2×EDO; 1×CL; | |||
| Crystal structure of BAK-BAX heterodimer with C12E8 |
Heteromer Q07812; Q16611; | 100 | 1×PG0; 2×PEG; 1×N8E; 1×P33; 1×PG4; | |||
| A viral protein unexpectedly mimics the structure and function of pro- survival Bcl-2 |
Heteromer Q16611; Q85295; | 100 | 1×NA; | |||
| BakBH3 in complex with sjA |
Heteromer Q16611; Q5BWX6; | 100 | ||||
| Crystal structure of BHRF1:Bak BH3 complex |
Heteromer P03182; Q16611; | 100 | 4×NO3; 2×EDO; | |||
| Crystal structure of variola virus virulence factor F1L in complex with human Bak BH3 domain |
Heteromer Q16611; Q85365; | 100 | 2×CL; 1×ACT; | |||
| Deerpox virus DPV022 in complex with Bak BH3 |
Heteromer Q08FX8; Q16611; | 100 | 2×SO4; | |||
| Vaccinia Virus F1L bound to Bak BH3 |
Heteromer O57173; Q16611; | 95.45 | ||||
| Bcl-xL with Bak BH3 complex |
Heteromer Q07817; Q16611; | 100 | 8×GOL; | |||
| Crystal structure of human BFL-1 in complex with BAK BH3 peptide |
Heteromer Q16548; Q16611; | 100 | ||||
| SOLUTION STRUCTURE OF AN APOPTOSIS ACTIVATING PHOTOSWITCHABLE BAK PEPTIDE BOUND to BCL-XL |
Heteromer Q07817; Q16611; | 68.75 | 1×33B; | |||
| STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, MINIMIZED AVERAGE STRUCTURE |
Heteromer Q07817; Q16611; | 100 | ||||
| The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site | homo-2-mer | 100 | 2×ZN; | |||
| The X-ray Structure of a Bak Homodimer Reveals an Inhibitory Zinc Binding Site | homo-2-mer | 100 | 2×ZN; | |||
| Human Bak Q77L | homo-2-mer | 98.77 | 6×ZN; | |||
| Bak L100A | homo-2-mer | 98.76 | ||||
| Bak domain swapped dimer induced by BidBH3 with CHAPS | homo-2-mer | 99.31 | ||||
| Crystal Structure of human BAK in complex with WT BAK BH3 peptide | homo-2-mer | 99.34 | 1×CU; 1×SO4; | |||
| The crystal structure of a BAK dimer activated by detergent | homo-2-mer | 99.05 | ||||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylserine | homo-2-mer | 100 | 4×8SP; 3×SO4; | |||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with POPC and C8E4 | homo-2-mer | 100 | 3×SO4; 6×C8E; 3×EDO; 1×LBN; | |||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM | homo-2-mer | 100 | 3×LMT; 6×SO4; 1×ACT; 6×EDO; | |||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with LysoPC | homo-2-mer | 100 | 2×K6G; 1×PG4; 4×PGE; | |||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with phosphatidylglycerol | homo-2-mer | 100 | 1×PG8; | |||
| Bak BH3-in-Groove dimer (GFP) | homo-2-mer | 100 | 1×CAC; 1×MPD; | |||
| Crystal structure of BAK core domain BH3-groove-dimer in complex with E. coli lipid | homo-2-mer | 100 | 2×PEE; | |||
| BH3 domain swapped dimer of a BAK fragment | homo-2-mer | 100 | 2×SO4; 2×EPE; | |||
| The crystal structure of BAK1 - a mitochondrial apoptosis regulator | monomer | 100.0 | 1×SO4; | |||
| Crystal structure of human Bcl-2 family protein Bak | monomer | 100.0 | 1×SO4; | |||
| NMR structure of the Bak transmembrane helix in lipid nanodiscs | monomer | 100 | ||||
| NMR structure of the Bak transmembrane helix in DPC micelles | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2jcn.1.A | monomer | 0.79 | 99.42 | |||